Zelnorm bares its belly
Novartis' Zelnorm (tegaserod) DTC campaign emphasizes the symptoms of constipation-predominant irritable bowel syndrome. The television ads depict close-ups of women lifting their shirts and displaying words written on their stomachs. Messages include "I'm all twisted inside," "the bloating is so uncomfortable," and "I keep thinking about the pain" in Novartis' first branded campaign for IBS therapy (1"The Pink Sheet" July 28, 2003, p. 34)...
You may also be interested in...
Novartis is considering expanded use of direct-to-consumer ads based on the positive results of DTC campaigns for Elidel, Zelnorm and Lamisil
Novartis plans to launch a national DTC campaign for its irritable bowel syndrome agent Zelnorm early in the third quarter, the company announced during its July 21 investor conference call
A trio of newly finalized guidance documents from the US agency dated 25 September explain how the Accreditation Scheme for Conformity Assessment pilot will work, and what biocompatibility and safety standards will apply.